RA

Ran Achituv

Managing Partner at Entree Capital & Chairman of Advisory Board and Alumni at Efi Arazi School of Computer Science

Israel

CEO
VC
Investor

Invests in

Stages:

Seed

Locations:

Tel Aviv, Israel

  • Min Investment:

    $250,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,500,000.00

Skills

Product Management
Enterprise Software
SaaS
Cloud Computing
Software Development
Integration
Pre-sales
Mobile Devices
Software Project Management
Telecommunications
Product Marketing
Start-ups
Executive Management
Business Strategy
Strategic Partnerships
M&A experience
Leadership Development
Sales Management
Strategic Planning
Vision

Education

Investments

MagnusMetal

Series B

Total Funding: $74M

IRP Systems

Seed

Total Funding: $51M

Identiq

Seed

Total Funding: $100M

Toka

Seed

Total Funding: $38M

PayKey

Seed

Total Funding: $16M

E8 Storage

Series A

Total Funding: $18M

Argus Cyber Security

Series A

Total Funding: $25M

Work Experience

Diamond Electronics

2023

  • Board Member

    2023

    Next Generation Power Electronics

Entrée Capital

2018

  • Managing Partner

    2018

Efi Arazi School of Computer Science

2019

  • Chairman of Advisory Board and Alumni

    2019

Cavos Biotech LTD

2024

  • Investor

    2024

    Developing novel drugs based on naturally occurring resistance mechanisms

Web 3.0 Blockchain Stealth

2024

  • Investor

    2024

    Making blockchain and the Web3 economy a reality

Quantum Transistors

2022

  • Board Member

    2022

    As the name implies , the 8086 of Quantum.

Quantum Art

2022

  • Board Observer

    2022

Classiq Technologies

2020

  • Board Member, Chairman

    2020

    Classiq brings the quantum software stack to a new level of abstraction, empowering quantum software developers and enabling the development of world-changing quantum algorithms and applications.

LightSolver

2020

  • Board Member

    2020

    Stealth mode Quantum Computing Lighting-up the world of computation

NVision Imaging Technologies

2023

  • Investor and Board Observer

    2023

    NVision is a developer of Quantum based MRI polarizers and hyperpolarized imaging agents. The company’s hyperpolarization technology permits the assessment of human and animal metabolism by standard MRI, enabling advanced preclinical and clinical applications, including novel cancer diagnosis and monitoring of response to therapy. 2023 delivery of first polarizers to users.